Filter News
Area of Research
News Topics
- (-) Biomedical (27)
- 3-D Printing/Advanced Manufacturing (35)
- Advanced Reactors (18)
- Artificial Intelligence (23)
- Big Data (16)
- Bioenergy (26)
- Biology (23)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (8)
- Clean Water (3)
- Composites (2)
- Computer Science (48)
- Coronavirus (25)
- Critical Materials (2)
- Cybersecurity (4)
- Energy Storage (21)
- Environment (33)
- Exascale Computing (11)
- Fossil Energy (1)
- Frontier (7)
- Fusion (18)
- Grid (10)
- High-Performance Computing (16)
- Isotopes (11)
- ITER (1)
- Machine Learning (13)
- Materials (4)
- Materials Science (42)
- Mathematics (2)
- Mercury (1)
- Microscopy (11)
- Molten Salt (3)
- Nanotechnology (20)
- National Security (7)
- Neutron Science (43)
- Nuclear Energy (39)
- Partnerships (6)
- Physics (16)
- Polymers (9)
- Quantum Computing (9)
- Quantum Science (27)
- Security (4)
- Simulation (5)
- Space Exploration (3)
- Summit (20)
- Transportation (17)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 27 Results

Jesse Labbé aims to leverage biology, computation and engineering to address societal challenges related to energy, national security and health, while enhancing U.S. competitiveness. Labbé emphasizes the importance of translating groundbreaking research into practical applications that have real-world impact.

Scientists at the Department of Energy’s Oak Ridge National Laboratory recently welcomed Vanderbilt University colleagues for a symposium on basic science research, with a focus on potential collaborations in the biomedical and biotechnology spaces.
Daniel Jacobson, distinguished research scientist in the Biosciences Division at ORNL, has been elected a Fellow of the American Institute for Medical and Biological Engineering, or AIMBE, for his achievements in computational biology.

Researchers at Georgia State University used the Summit supercomputer to study an elaborate molecular pathway called nucleotide excision repair. Decoding NER’s sophisticated sequence of events and the role of PInC in the pathway could provide key insights into developing novel treatments and preventing conditions that lead to premature aging and certain types of cancer.

Ryan Culler is the program manager at Oak Ridge National Laboratory, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.

A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.

NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.

Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.

When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.